{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17369967",
  "DateCompleted": {
    "Year": "2007",
    "Month": "11",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "11",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2007",
        "Month": "03",
        "Day": "08"
      }
    ],
    "Language": [
      "spa"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0716-1018",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "1",
        "PubDate": {
          "Year": "2007",
          "Month": "Feb"
        }
      },
      "Title": "Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia",
      "ISOAbbreviation": "Rev Chilena Infectol"
    },
    "ArticleTitle": "[Febrile neutropenia in children with cancer in a medical center of Santiago, Chile].",
    "Pagination": {
      "StartPage": "27",
      "EndPage": "32",
      "MedlinePgn": "27-32"
    },
    "Abstract": {
      "AbstractText": [
        "Febrile neutropenia in cancer patients is a common complication associated to chemotherapy and can be the first manifestation of a potentially lethal infection. In order to adapt our clinical practice to national clinical guidelines, we performed a retrospective review of clinical charts of all children admitted to the Pediatric Unit of Clinica Davila, from May 1, 2003 to December 31, 2004, with cancer, fever and neutropenia. A total of 57 febrile neutropenic episodes occurred in 25 children and in 44% (25/57) of them an infectious focus could be identified; respiratory infections were the most common (11/25). A microorganism could be identified in 16/57 (x%) of episodes, e.g. 12 recovered from blood cultures (42% coagulase negative Staphylococcus, 17% group viridans Streptococci, 17% Escherichia coli and Enterococcus sp, Candida albicans y Pseudomonas aeruginosa in 8% each one), 3 from a catheter (coagulase negative Staphylococci) and 1 from a bronchoalveolar lavage (Pneumocystis jiroveci). At admission, 63% of children received treatment with 2 antibiotics, mostly ceftazidime and amikacin (39%) and 21% received vancomycin. In 37% of patients therapy required adjustment due to a poor response. Fifty six episodes had a favorable resolution with one patient diying of septic shock. Frequency of microorganism detection, the distribution of species recovered and the favorable resolution are comparable to that reported from industrialized countries."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servicio de Pediatr\u00eda, Cl\u00ednica D\u00e1vila, Santiago, Chile. marcearnello@yahoo.com"
          }
        ],
        "LastName": "Arnello L",
        "ForeName": "Marcela",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Quintana B",
        "ForeName": "Juan A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Barraza C",
        "ForeName": "Pamela",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Neutropenia febril en ni\u00f1os con c\u00e1ncer en un centro asistencial en Santiago, Chile."
  },
  "MedlineJournalInfo": {
    "Country": "Chile",
    "MedlineTA": "Rev Chilena Infectol",
    "NlmUniqueID": "9305754",
    "ISSNLinking": "0716-1018"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    }
  ]
}